These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 9816024)
1. Removal of carcinoma cells from contaminated bone marrow using the lipophilic cation rhodamine 123. Wong JR; Ho C; Mauch P; Coleman N; Berman S; Chen LB Clin Cancer Res; 1995 Jun; 1(6):621-30. PubMed ID: 9816024 [TBL] [Abstract][Full Text] [Related]
2. Antileukemic effect of interleukin-2-transduced murine bone marrow after autologous transplantation. Tam YK; Klingemann HG Biol Blood Marrow Transplant; 1999; 5(4):231-42. PubMed ID: 10465103 [TBL] [Abstract][Full Text] [Related]
3. AA1, a newly synthesized monovalent lipophilic cation, expresses potent in vivo antitumor activity. Sun X; Wong JR; Song K; Hu J; Garlid KD; Chen LB Cancer Res; 1994 Mar; 54(6):1465-71. PubMed ID: 8137249 [TBL] [Abstract][Full Text] [Related]
4. Cell cycle-based purging of lymphoma cells from bone marrow harvests using radioiodinated 5-iodo-2'-deoxyuridine. Schneiderman MH; Jackson JD; Joshi SS; Clark-Pierce L; Murphy BJ; Schneiderman GS Radiat Res; 1998 Feb; 149(2):147-54. PubMed ID: 9457894 [TBL] [Abstract][Full Text] [Related]
5. Efficient and nontoxic adenoviral purging method for autologous transplantation in breast cancer patients. Lillo R; Ramírez M; Alvarez A; Santos S; García-Castro J; Fernández de Velasco J; Avilés MJ; Gómez-Pineda A; Díez JL; Balas A; Vicario JL; Bueren JA; García-Sánchez F Cancer Res; 2002 Sep; 62(17):5013-8. PubMed ID: 12208755 [TBL] [Abstract][Full Text] [Related]
6. Disseminated tumor cells in bone marrow of patients with transitional cell carcinoma: immunocytochemical detection and correlation with established prognostic indicators. Hofmann T; Riesenberg R; Buchner A; Zimmermann W; Hofstetter A; Oberneder R J Urol; 2003 Apr; 169(4):1303-7. PubMed ID: 12629348 [TBL] [Abstract][Full Text] [Related]
7. A novel HSV-1 virus, JS1/34.5-/47-, purges contaminating breast cancer cells from bone marrow. Hu JC; Booth MJ; Tripuraneni G; Davies D; Zaidi SA; Tamburo de Bella M; Slade MJ; Marley SB; Gordon MY; Coffin RS; Coombes RC; Kamalati T Clin Cancer Res; 2006 Nov; 12(22):6853-62. PubMed ID: 17121907 [TBL] [Abstract][Full Text] [Related]
8. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019 [TBL] [Abstract][Full Text] [Related]
9. Purging of murine erythroblastic leukemia by ZnPcS2P2-based-photodynamic therapy. Huang HF; Chen YZ; Wu Y; Chen P Bone Marrow Transplant; 2006 Jan; 37(2):213-7. PubMed ID: 16284611 [TBL] [Abstract][Full Text] [Related]
10. Purging of leukemia-contaminated bone marrow grafts using suicide adenoviral vectors: an in vivo murine experimental model. Garcia-Castro J; Rio P; Lillo R; Garcia-Sanchez F; Segovia JC; Bueren JA Gene Ther; 2003 Aug; 10(16):1328-35. PubMed ID: 12883529 [TBL] [Abstract][Full Text] [Related]
11. [Establishment and application of a murine transplant model of bone marrow purging of metastatic breast cancer cells in vitro]. Hu ZP; Liu WL; Stuart B; Zhang YC Zhonghua Xue Ye Xue Za Zhi; 2007 Sep; 28(9):621-3. PubMed ID: 18246821 [TBL] [Abstract][Full Text] [Related]
12. Removal of breast cancer cells from bone marrow by in vitro purging with ether lipids and cryopreservation. Dietzfelbinger HF; Kühn D; Zafferani M; Hanauske AR; Rastetter JW; Berdel WE Cancer Res; 1993 Aug; 53(16):3747-51. PubMed ID: 8339286 [TBL] [Abstract][Full Text] [Related]
13. Antileukemic effect of interleukin-2-transduced murine bone marrow after autologous transplantation. Tam YK; Klingemann HG Biol Blood Marrow Transplant; 1999; 5(3):144-54. PubMed ID: 10392960 [TBL] [Abstract][Full Text] [Related]
14. Elimination of malignant tumor cells from human bone marrow using monoclonal antibodies and immunomagnetic beads. Wang SY; Makl KL; Chen LY; Tzeng CH; Hu CP; Chang C Anticancer Res; 1993; 13(6A):2281-5. PubMed ID: 8297147 [TBL] [Abstract][Full Text] [Related]
15. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204 [TBL] [Abstract][Full Text] [Related]
16. NTP Toxicology and Carcinogenesis Studies 2-Butoxyethanol (CAS NO. 111-76-2) in F344/N Rats and B6C3F1 Mice (Inhalation Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 2000 Mar; 484():1-290. PubMed ID: 12571679 [TBL] [Abstract][Full Text] [Related]
17. Separation of clonogenic tumor cells from small cell lung cancer bone marrow and small cell lung cancer cell lines. Gordon LI; Rosen ST; Vriesendorp HM; Kies MS; Kucuk O Cancer Res; 1984 Nov; 44(11):5404-8. PubMed ID: 6091877 [TBL] [Abstract][Full Text] [Related]
18. Negative selection and protection of normal progenitor cells for autografting. Douay L Bone Marrow Transplant; 1998 Sep; 22(5):423-30. PubMed ID: 9733264 [TBL] [Abstract][Full Text] [Related]
19. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653 [TBL] [Abstract][Full Text] [Related]
20. Toxicology and carcinogenesis studies of p-nitrotoluene (CAS no. 99-99-0) in F344/N rats and B6C3F(1) mice (feed studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 2002 May; (498):1-277. PubMed ID: 12118261 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]